Financials Check-Cap Ltd.

Equities

CHEK

IL0011336851

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-05-03 pm EDT 5-day change 1st Jan Change
2.2 USD -2.22% Intraday chart for Check-Cap Ltd. -3.72% +5.77%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 16.75 11.46 14.22 21.27 65.04 12.81
Enterprise Value (EV) 1 9.7 -2.79 6.955 3.865 14.62 -27.93
P/E ratio -1.55 x -0.82 x -0.99 x -1.01 x -3.25 x -0.65 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -0.99 x 0.26 x -0.5 x -0.28 x -0.85 x 1.42 x
EV / FCF -1.74 x 0.43 x -0.87 x -0.47 x -1.36 x 2.31 x
FCF Yield -57.4% 232% -115% -214% -73.3% 43.3%
Price to Book 2.84 x 0.88 x 2.28 x 1.3 x 1.28 x 0.31 x
Nbr of stocks (in thousands) 80.2 266 413 2,312 4,820 5,824
Reference price 2 208.8 43.00 34.40 9.200 13.49 2.200
Announcement Date 4/4/18 3/28/19 3/6/20 3/18/21 4/6/22 3/31/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -9.844 -10.64 -13.95 -13.78 -17.12 -19.69
EBIT 1 -10 -10.78 -14.07 -13.93 -17.32 -20.03
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -9.765 -10.59 -13.84 -13.85 -17.2 -19.11
Net income 1 -9.771 -10.59 -13.84 -13.85 -17.2 -19.11
Net margin - - - - - -
EPS 2 -134.3 -52.19 -34.65 -9.124 -4.155 -3.369
Free Cash Flow 1 -5.569 -6.476 -7.974 -8.278 -10.71 -12.09
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/4/18 3/28/19 3/6/20 3/18/21 4/6/22 3/31/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - - - - - - - - - - -
EBITDA - - - - - - - - - - -
EBIT 1 -3.557 -3.923 -4.263 -5.578 -5.885 -4.888 -5.045 -4.215 -4.85 -6.063 -2.863
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) 1 -3.566 -3.918 -4.241 -5.477 -5.834 -4.807 -4.754 -3.713 -4.442 -6.878 -2.59
Net income 1 -3.566 -3.918 -4.241 -5.477 -5.834 -4.807 -4.754 -3.713 -4.442 -6.878 -2.59
Net margin - - - - - - - - - - -
EPS 2 -1.000 -1.200 -0.8000 -1.200 -1.200 -0.8000 -0.8000 -0.6350 -0.7600 -1.180 -0.4400
Dividend per Share - - - - - - - - - - -
Announcement Date 5/12/21 8/5/21 11/3/21 4/6/22 6/1/22 8/31/22 11/30/22 3/31/23 5/11/23 8/4/23 11/27/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 7.05 14.2 7.26 17.4 50.4 40.7
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5.57 -6.48 -7.97 -8.28 -10.7 -12.1
ROE (net income / shareholders' equity) -120% -112% -144% -122% -51.3% -41.5%
ROA (Net income/ Total Assets) -61.9% -57.7% -70.7% -59.9% -28.8% -24.8%
Assets 1 15.79 18.34 19.56 23.11 59.82 77.14
Book Value Per Share 2 73.60 48.90 15.10 7.080 10.50 7.070
Cash Flow per Share 2 87.20 32.20 18.60 3.330 5.490 0.7000
Capex 1 0.23 0.09 0.17 0.38 1.01 0.49
Capex / Sales - - - - - -
Announcement Date 4/4/18 3/28/19 3/6/20 3/18/21 4/6/22 3/31/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. CHEK Stock
  4. Financials Check-Cap Ltd.